Self‐Assembling P38 Peptide Inhibitor Nanoparticles Ameliorate the Transition from Acute to Chronic Kidney Disease by Suppressing Ferroptosis (Adv. Healthcare Mater. 23/2024)

Documenti analoghi

• Self‐Assembling P38 Peptide Inhibitor Nanoparticles Ameliorate the Transition from Acute to Chronic Kidney Disease by Suppressing Ferroptosis
  di: Wang Xin, et al.
  Pubblicazione: (2024)
• Supramolecular Heterodimer Peptides Assembly for Nanoparticles Functionalization (Adv. Healthcare Mater. 15/2024)
  di: Clélia Mathieu, et al.
  Pubblicazione: (2024)
• Atomic Artificial Enzyme for Acute and Chronic Pneumonia (Adv. Healthcare Mater. 9/2025)
  di: Wei Liu, et al.
  Pubblicazione: (2025)
• Multienzyme Active Manganese Oxide Alleviates Acute Liver Injury by Mimicking Redox Regulatory System and Inhibiting Ferroptosis (Adv. Healthcare Mater. 11/2024)
  di: Aimin Wu, et al.
  Pubblicazione: (2024)
• Ultrasound‐Responsive Macrophage Biomimetic Phase‐Change Nanoparticles for Delivering miR‐126 Ameliorate Murine Heart Transplant Rejection (Adv. Healthcare Mater. 19/2026)
  di: Haichao Yang, et al.
  Pubblicazione: (2026)